Pfizer Inc March 16, 2022 10:39 am Pfizer Requests FDA Authorization for 2nd Booster in Seniors Pfizer asked the FDA Tuesday to authorize a second booster dose of its COVID-19 vaccine for Americans ages 65 and over. Local 2:15 CDC could remove 5-day isolation recommendation for COVID: Report 2:55 Flu, COVID, RSV rising at Chicago hospitals, doctor says 1:50 IDPH says COVID-19 hospitalizations are on the rise in parts of Illinois 0:25 COVID symptoms 2023: Chicago-area doctor reveals what she's seeing most 1:49 Free COVID tests available by mail once again